Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Chinese ST-Segment Elevation Myocardial Infarction Primary Percutaneous Coronary Intervention Registry

NCT04996901 is registered in ClinicalTrials.gov with Renmin Hospital of Wuhan University as lead sponsor.

NCT NCT04996901
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04996901 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Chinese ST-Segment Elevation Myocardial Infarction Primary Percutaneous Coronary Intervention Registry
Lead sponsor
Renmin Hospital of Wuhan University
Phase
Observational
Overall status
Completed
Start date
May 22, 2021
Completion date
December 5, 2021
Enrollment
5,594 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

st-segment elevation myocardial infarction (stemi)